The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema. Diabetic retinopathy (DR) is the most common diabetic eye disease and is a leading cause of blindness in adults in the…
Source:FDA approves new treatment for diabetic retinopathy in patients with diabetic macular edema
Wednesday, March 25, 2015
FDA approves new treatment for diabetic retinopathy in patients with diabetic macular edema
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment